2019/6/4 / Last updated : 2019/7/2 wpmaster Latest news Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets GEXVal Inc. June 4th, 2019 Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets […]
2019/4/26 / Last updated : 2019/6/24 wpmaster Latest news GEXVal participates in CHINABIO PARTNERINGFURUM 2019 GEXVal Inc. April 26, 2019 GEXVal participates in CHINABIO PARTNERING FURUM 2019 GEXVal will participate in t […]
2019/4/22 / Last updated : 2019/6/26 wpmaster Latest news GEXVal Appeared in Nikkei, Japan’s Largest Financial Paper GEXVal Inc. April 22, 2019 GEXVal Appeared in Nikkei, Japan’s Largest Financial Paper In an article high […]
2019/1/19 / Last updated : 2019/7/2 wpmaster Latest news GEXVal gives presentation at BIO-Asia 2019 GEXVal Inc. January 19, 2019 GEXVal gives presentation at BIO-Asia 2019 GEXVal will make a presentation to the […]
2018/12/7 / Last updated : 2019/4/26 wpmaster Latest news GEXVal CEO Kato speaks in San Diego Trade Mission Panel Discussion GEXVal Inc. December 7, 2018 GEXVal CEO Kato speaks in San Diego Trade Mission Panel Discussion GEXVal Preside […]
2018/11/9 / Last updated : 2019/7/2 wpmaster Latest news GEXVal participated in BIO-EUROPE 2018 GEXVal Inc. November 19, 2018 GEXVal participated in BIO-EUROPE 2018 GEXval Inc. participated in BIO-EUROPE 20 […]
2018/9/28 / Last updated : 2018/10/5 wpmaster Latest news GEXVal exhibits at JAPAN HEALTHCARE VENTURE SUMMIT 2018 GEXVal Inc. September 28th, 2018 GEXVal exhibits at JAPAN HEALTHCARE VENTURE SUMMIT 2018 We are pleased to ann […]
2018/8/1 / Last updated : 2019/1/8 wpmaster Latest news GEXVal selected by METI for the project of ‘2018 Support Regional Core Enterprise Innovation’ GEXVal selected by Ministry of Economy,Trade and Industry (METI) for the project of ‘2018 Support […]
2018/6/29 / Last updated : 2018/10/5 wpmaster Latest news GEXVal exhibits in BIOtech Japan 2018 GEXVal Inc. June 29, 2018 GEXVal Exhibits in BIOtech Japan 2018 GEXVal Inc., took a part in BIOtech Ja […]
